IoT医療機器市場 – 2030年までの世界予測

IoT Medical Devices Market - Global Forecast to 2030

IoT医療機器市場 - 製品 {ウェアラブル [バイタルサイン(血圧、血糖値、心電図、酸素濃度計)、呼吸数、胎児]、インプラント(神経、心臓除細動器、ペースメーカー)ポンプ}、接続性(Bluetooth、WiFi)、エンドユーザー(病院、介護施設)および地域別 - 2030年までの世界予測
IoT Medical Devices Market by Product (Wearable (Vital Sign (BP, Glucose, ECG, Oximeter), Resp., Fetal), Implant (Neuro, Cardiac-Defib, Pacemaker) Pumps), Connectivity (Bluetooth, WiFi), End User (Hospital, Nursing Home) & Region - Global Forecast to 2030

商品番号 : SMB-4233

出版社MarketsandMarkets
出版年月2025年6月
ページ数330
図表数356
価格タイプシングルユーザライセンス
価格USD 4,950
種別英文調査報告書

本レポートは、IoT医療機器市場を分析し、製品、タイプ、接続技術、エンドユーザー、地域に基づいて、様々な市場セグメントの市場規模と将来の成長ポテンシャルを推定することを目的としています。また、この市場で活動する主要企業の競合分析に加え、各社の企業概要、製品ラインナップ、最近の動向、主要な市場戦略についても提供しています。

The global IoT medical devices market is projected to reach USD 154.74 billion by 2030, up from USD 65.08 billion in 2025, reflecting a CAGR of 18.9% during this period. The market is growing rapidly due to an increasing demand for continuous and real-time patient monitoring, particularly with the wider adoption of telehealth. Recent innovations in low-energy sensors, 5G networks, and edge computing have made it possible to efficiently collect and transmit data from wearable and implantable devices to healthcare systems. These advancements enable more proactive and decentralized care, leading to fewer hospital readmissions. Furthermore, the rising incidence of chronic conditions and an aging global population are driving the greater use of these technologies in both home and clinical settings.

世界のIoT医療機器市場は、2025年の650億8000万米ドルから2030年には1,547億4000万米ドルに達し、この期間に年平均成長率(CAGR)18.9%で成長すると予測されています。この市場は、特に遠隔医療の普及に伴い、継続的かつリアルタイムの患者モニタリングに対する需要が高まっていることから、急速に成長しています。低消費電力センサー、5Gネットワ​​ーク、エッジコンピューティングにおける近年のイノベーションにより、ウェアラブルデバイスやインプラントデバイスから医療システムにデータを効率的に収集・送信することが可能になりました。これらの進歩により、より積極的かつ分散化されたケアが可能になり、入院再発の減少につながります。さらに、慢性疾患の罹患率の上昇と世界的な人口高齢化により、家庭と医療現場の両方でこれらの技術の利用が拡大しています。

IoT医療機器市場 - 2030年までの世界予測
iot-medical-device-market-Overview

However, the market faces challenges, such as the complexity of integrating with legacy health IT infrastructure, compliance with data privacy regulations like HIPAA and GDPR, and the need to maintain strong cybersecurity to protect patient information in an increasingly connected ecosystem.

しかし、市場は、従来の医療 IT インフラストラクチャとの統合の複雑さ、HIPAA や GDPR などのデータ プライバシー規制への準拠、ますます接続が進むエコシステムで患者情報を保護するための強力なサイバー セキュリティを維持する必要性などの課題に直面しています。

“The hospitals & clinics segment, under the IoT medical devices market, is expected to register the fastest growth during the forecast period.”

In 2024, the hospitals & clinics segment emerged as the leading end user segment in the IoT medical devices market, a position it is expected to maintain in the coming years. This leadership is primarily due to the increasing demand for advanced diagnostic, monitoring, and treatment tools within healthcare facilities. By adopting IoT-enabled technologies, these institutions can enhance patient outcomes through real-time data monitoring, remote care capabilities, and streamlined clinical operations. The ability to continuously track patient vital signs and chronic health conditions allows for quicker interventions and more effective care delivery. Additionally, the integration of IoT with electronic health records (EHRs) and clinical decision-making platforms improves data accuracy and fosters better coordination among care teams. Key factors driving this trend include the push for higher efficiency, rising patient volumes, and the necessity to meet stringent regulatory and quality standards. As a result, hospitals and clinics are making substantial investments in IoT technologies to improve performance, ensure compliance, and provide more responsive, personalized patient care.

“Bluetooth-enabled IoT technology is projected to dominate the IoT medical devices market during the forecast period.”

Bluetooth-enabled IoT technology is rapidly emerging as the fastest-growing connectivity option in the IoT medical devices market. This growth is primarily driven by its energy efficiency, easy integration, and wide compatibility with smartphones, tablets, and wearable healthcare devices. As more healthcare organizations adopt connected solutions for continuous monitoring and patient interaction, Bluetooth has become a reliable and cost-effective method for short-range data exchange. It plays a vital role in devices such as fitness trackers, mobile diagnostic equipment, and home health monitoring tools, where low power consumption and consistent data transfer are crucial.

IoT医療機器市場 - 2030年までの世界予測 region
iot-medical-device-market-Region

“Asia Pacific is expected to register fastest market growth during the forecast period.”

The Asia Pacific region is expected to experience the fastest growth in the IoT medical devices market during the forecast period. This growth is primarily driven by the rapid adoption of digital healthcare technologies, including IoT and artificial intelligence. Government initiatives aimed at improving healthcare infrastructure, combined with significant investments in smart hospitals and digital health platforms, are leading to the increased deployment of connected medical devices. Additionally, the rising demand for remote monitoring solutions, fueled by a growing elderly population and an increase in chronic health conditions, is further propelling this trend. Furthermore, enhanced telecommunications networks and supportive regulatory frameworks for digital health services are facilitating the implementation of IoT-based solutions. As a result, Asia-Pacific is emerging as a key player in the global expansion of the IoT medical device industry.

The breakdown of primary participants is as mentioned below:

  • By Company Type – Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
  • By Designation – C-level: 42%, Director-level: 31%, and Others: 27%
  • By Region – North America: 32%, Asia Pacific: 32%, Europe: 26%, Latin America: 5% and Middle East & Africa: 5%

Key Players in the IoT Medical Devices Market

The key players functioning in the IoT medical devices market include Medtronic (Ireland), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Abbott (US), Boston Scientific Corporation (US), OMRON Corporation (Japan), Baxter International Inc. (US), BIOTRONIK (Germany), Johnson & Johnson Private Limited (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany), Honeywell International Inc. (US), AliveCor, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Nonin (US), AMD Global Telemedicine (US), iHealth Labs Inc (US), Aerotel Medical Systems (1998) Ltd. (Israel), i-SENS, Inc. (Korea), Huntleigh Healthcare Limited (UK), ResMed (US), Masimo (US), Infinium Medical (US), ICU Medical, Inc. (US), and  Hamilton Medical (Switzerland).

IoT医療機器市場 - 2030年までの世界予測 ecosystem
iot-medical-device-market-Ecosystem

Research Coverage

The report analyzes the IoT medical devices market and aims to estimate the market size and future growth potential of various market segments based on product, type, connectivity technology, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will provide valuable insights for both, established companies and new or smaller firms, helping them understand market trends and dynamics. By doing so, they can increase their market share. Companies that purchase this report can employ one or more of the strategies outlined below to enhance their positions in the market.

This report provides insights on:

  • Analysis of key drivers: Drivers (government initiatives to promote digital health), restraints (high deployment cost of connected medical devices), opportunities (low doctor-to-patient ratio in several countries), and challenges (data security issues) are key factors influencing the growth of the IoT medical devices market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the IoT medical devices market
  • Market Development: Comprehensive information on the lucrative emerging markets, product, type, connectivity technology, end user, and region
  • Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, and investments in the IoT medical devices market
  • Competitive Assessment: In-depth assessment of market ranking, growth strategies, product offerings, and capabilities of the leading players in the IoT medical devices market like Medtronic (Ireland), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Abbott (US), and Boston Scientific Corporation (US)

Table of Contents

1               INTRODUCTION              28

1.1           STUDY OBJECTIVES       28

1.2           MARKET DEFINITION   28

1.3           MARKET SCOPE                29

1.3.1        MARKETS COVERED       29

1.3.2        INCLUSIONS AND EXCLUSIONS 29

1.3.3        YEARS CONSIDERED      30

1.3.4        CURRENCY CONSIDERED            30

1.4           STAKEHOLDERS               30

1.5           SUMMARY OF CHANGES               31

2               RESEARCH METHODOLOGY       32

2.1           RESEARCH DESIGN         32

2.1.1        RESEARCH DATA              32

2.1.2        SECONDARY SOURCES  32

2.1.2.1    Key data from secondary sources       33

2.1.3        PRIMARY SOURCES         33

2.1.3.1    Key data from primary sources           34

2.1.3.2    Key industry insights           35

2.2           MARKET SIZE ESTIMATION         36

2.3           MARKET BREAKDOWN AND DATA TRIANGULATION                 39

2.4           LIMITATIONS    40

2.5           MARKET SHARE ANALYSIS           40

2.6           ASSUMPTIONS  40

2.7           RISK ASSESSMENT           40

3               EXECUTIVE SUMMARY  41

4               PREMIUM INSIGHTS       46

4.1           IOT MEDICAL DEVICES MARKET OVERVIEW       46

4.2           ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY TYPE AND COUNTRY 47

4.3           GEOGRAPHIC GROWTH OPPORTUNITIES IN IOT MEDICAL DEVICES MARKET       48

4.4           REGIONAL MIX: IOT MEDICAL DEVICES MARKET                 48

4.5           IOT MEDICAL DEVICES MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES  49

5               MARKET OVERVIEW       50

5.1           INTRODUCTION              50

5.2           MARKET DYNAMICS       50

5.2.1        DRIVERS               51

5.2.1.1    Government initiatives to promote digital health            51

5.2.1.2    Growing need for cost-containment in healthcare delivery                 52

5.2.1.3    Rising focus on patient engagement and patient-centric healthcare               53

5.2.1.4    Evolution of high-speed networking technologies           53

5.2.1.5    Growing focus on patient safety         54

5.2.2        RESTRAINTS      55

5.2.2.1    High deployment costs of connected medical devices    55

5.2.2.2    Lack of skilled IT personnel across healthcare organizations                 55

5.2.3        OPPORTUNITIES              56

5.2.3.1    Low doctor-to-patient ratio in several countries              56

5.2.4        CHALLENGES    56

5.2.4.1    Data security issues              56

5.2.4.2    Data management and interoperability concerns            60

5.3           INDUSTRY INSIGHTS     60

5.3.1        INCREASING NUMBER OF PRODUCT LAUNCHES                 60

5.3.2        GROWING INTEGRATION OF CLOUD PLATFORMS AND SAAS IN HEALTHCARE ECOSYSTEM        61

5.3.3        INCREASING NUMBER OF COLLABORATIONS TO DRIVE INNOVATION    62

5.4           TECHNOLOGY ANALYSIS             62

5.5           PORTER’S FIVE FORCES ANALYSIS           63

5.5.1        INTENSITY OF COMPETITIVE RIVALRY 64

5.5.2        BARGAINING POWER OF SUPPLIERS       64

5.5.3        BARGAINING POWER OF BUYERS             64

5.5.4        THREAT OF NEW ENTRANTS      64

5.5.5        THREAT OF SUBSTITUTES          65

5.6           KEY STAKEHOLDERS AND BUYING CRITERIA     65

5.6.1        KEY STAKEHOLDERS IN BUYING PROCESS           65

5.6.2        BUYING CRITERIA           66

5.7           REGULATORY ANALYSIS               66

5.7.1        NORTH AMERICA             66

5.7.1.1    US           66

5.7.1.2    Canada   71

5.7.2        EUROPE               71

5.7.3        ASIA PACIFIC     72

5.7.3.1    Japan      72

5.7.3.2    China      73

5.7.3.3    India       73

5.8           VALUE CHAIN ANALYSIS               74

5.9           ECOSYSTEM ANALYSIS  75

5.10         PRICING ANALYSIS          75

5.11         PATENT ANALYSIS          76

5.11.1      INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS            76

5.11.2      LIST OF MAJOR PATENTS             78

5.12         CASE STUDY ANALYSIS 80

5.12.1      CASE STUDY 1: ADVANCING WOUND MEASUREMENT ACCURACY IN HEALTHCARE WITH IOT TECHNOLOGY 80

5.12.2      CASE STUDY 2: EMPOWERING PATIENT-CONTROLLED PAIN MEDICATION ADMINISTRATION WITH IOT TECHNOLOGY                 80

5.12.3      CASE STUDY 3: IMPROVING MATERNAL AND FETAL CARE WITH IOT-DRIVEN MONITORING SOLUTIONS      81

5.13         KEY CONFERENCES AND EVENTS, 2025–2026        81

5.14         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       82

5.15         IMPACT OF 2025 US TARIFFS—IOT MEDICAL DEVICES MARKET               82

5.15.1      INTRODUCTION              82

5.15.2      KEY TARIFF RATES          83

5.15.3      PRICE IMPACT ANALYSIS             84

5.15.4      IMPACT ON COUNTRY/REGION                85

5.15.4.1  US           85

5.15.4.2  Europe   86

5.15.4.3  Asia Pacific            87

5.15.5      IMPACT ON END-USE INDUSTRIES          88

6               IOT MEDICAL DEVICES MARKET, BY PRODUCT 91

6.1           INTRODUCTION              92

6.2           VITAL SIGNS MONITORING DEVICES     93

6.2.1        BLOOD GLUCOSE MONITORS   94

6.2.1.1    Preference for continuous glucose monitoring to drive market                 94

6.2.2        ECG/HEART RATE MONITORS   95

6.2.2.1    Rising incidence of CVD to drive market growth            95

6.2.3        BLOOD PRESSURE MONITORS  98

6.2.3.1    Growing prevalence of hypertension and obesity to fuel market                 98

6.2.4        MULTIPARAMETER MONITORS 100

6.2.4.1    Rising preference for home care to drive demand           100

6.2.5        OXIMETERS        101

6.2.5.1    Increasing focus on self-monitoring to drive market      101

6.3           IMAGING SYSTEMS         102

6.3.1        NEED TO TRANSMIT DATA FOR REMOTE VIEWING TO SUPPORT MARKET GROWTH     102

6.4           IMPLANTABLE CARDIAC DEVICES           104

6.4.1        IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS                 105

6.4.1.1    Growing geriatric population to boost demand               105

6.4.2        PACEMAKERS    107

6.4.2.1    Rising number of cardiac patients to drive demand        107

6.4.3        IMPLANTABLE CARDIAC MONITORS      108

6.4.3.1    Ease of remote monitoring to drive demand    108

6.5           PATIENT MONITORS     109

6.5.1        GROWING ADOPTION TO BOOST MARKET         109

6.6           RESPIRATORY DEVICES 111

6.6.1        RISING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE DEMAND               111

6.7           INFUSION PUMPS            112

6.7.1        RISK OF SECURITY BREACHES TO IMPACT MARKET GROWTH             112

6.8           FETAL MONITORING DEVICES  113

6.8.1        GROWING EMPHASIS ON FETAL HEALTH TO DRIVE MARKET GROWTH          113

6.9           NEUROLOGICAL DEVICES           115

6.9.1        TECHNOLOGICAL ADVANCEMENTS TO BOOST MARKET               115

6.10         VENTILATORS  117

6.10.1      HIGH DEMAND FOR INTENSIVE CARE TO DRIVE MARKET GROWTH          117

6.11         ANESTHESIA MACHINES               118

6.11.1      INCREASING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET 118

6.12         HEARING DEVICES          119

6.12.1      RISING ADOPTION OF ADVANCED AIDS TO BOOST MARKET               119

6.13         OTHER IOT MEDICAL DEVICES 120

7               IOT MEDICAL DEVICES MARKET, BY TYPE           122

7.1           INTRODUCTION              123

7.2           STATIONARY DEVICES  123

7.2.1        IMPROVED DATA ACCESSIBILITY TO DRIVE DEMAND                 123

7.3           IMPLANTABLE DEVICES               126

7.3.1        INCREASING INCIDENCE OF CVD AND NEUROLOGICAL DISEASES TO DRIVE DEMAND   126

7.4           WEARABLE DEVICES      128

7.4.1        RISING USE IN HOME CARE SETTINGS TO PROPEL MARKET               128

7.5           OTHER DEVICE TYPES  129

8               IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY  131

8.1           INTRODUCTION              132

8.2           WI-FI     132

8.2.1        ABILITY TO PROVIDE GREATER FLEXIBILITY TO CAREGIVERS TO SUPPORT MARKET GROWTH   132

8.3           BLUETOOTH     133

8.3.1        SEAMLESS CONNECTION BETWEEN WIRELESS DEVICES TO FOSTER ADOPTION 133

8.4           ZIGBEE 134

8.4.1        SECURITY CONCERNS TO LIMIT ADOPTION      134

8.5           OTHER CONNECTIVITY TECHNOLOGIES             135

9               IOT MEDICAL DEVICES MARKET, BY END USER 136

9.1           INTRODUCTION              137

9.2           HOSPITALS & CLINICS   138

9.2.1        NEED TO REDUCE HEALTHCARE COSTS TO DRIVE MARKET               138

9.3           NURSING HOMES, ASSISTED LIVING FACILITIES, LONG-TERM CARE CENTERS,

AND HOME CARE SETTINGS       139

9.3.1        INCREASING GERIATRIC POPULATION TO CONTRIBUTE TO SEGMENT GROWTH   139

9.4           OTHER END USERS         140

10            IOT MEDICAL DEVICES MARKET, BY REGION     141

10.1         INTRODUCTION              142

10.2         NORTH AMERICA             143

10.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 143

10.2.2      US           147

10.2.2.1  High adoption of connected devices to drive market      147

10.2.3      CANADA               150

10.2.3.1  Government investments in health-related technologies

to boost market     150

10.3         EUROPE               153

10.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      154

10.3.2      GERMANY           157

10.3.2.1  Government initiatives to boost market            157

10.3.3      UK          160

10.3.3.1  High penetration of wearables to drive market                160

10.3.4      FRANCE                163

10.3.4.1  Government support for e-Health to drive market         163

10.3.5      ITALY    166

10.3.5.1  Widespread use of mobile devices to drive market          166

10.3.6      SPAIN    169

10.3.6.1  Growing geriatric population to propel demand              169

10.3.7      REST OF EUROPE             172

10.4         ASIA PACIFIC     175

10.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 175

10.4.2      CHINA  179

10.4.2.1  High burden of chronic disorders to drive demand        179

10.4.3      JAPAN   182

10.4.3.1  Demand from large geriatric population to boost market                 182

10.4.4      INDIA    185

10.4.4.1  Growing adoption of telemedicine to boost market        185

10.4.5      REST OF ASIA PACIFIC   188

10.5         LATIN AMERICA                192

10.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 192

10.5.2      BRAZIL 196

10.5.2.1  Increasing government initiatives to drive market          196

10.5.3      MEXICO                199

10.5.3.1  Focus on digitalization of healthcare to support market 199

10.5.4      REST OF LATIN AMERICA             202

10.6         MIDDLE EAST & AFRICA                205

10.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 206

10.6.2      GCC COUNTRIES              209

10.6.3      REST OF MIDDLE EAST & AFRICA             212

11            COMPETITIVE LANDSCAPE         216

11.1         INTRODUCTION              216

11.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            216

11.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN IOT MEDICAL DEVICES MARKET         217

11.3         REVENUE ANALYSIS, 2024             218

11.4         MARKET SHARE ANALYSIS, 2024                 218

11.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 221

11.5.1      STARS   221

11.5.2      EMERGING LEADERS     221

11.5.3      PERVASIVE PLAYERS      221

11.5.4      PARTICIPANTS 221

11.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         223

11.5.5.1  Company footprint               223

11.5.5.2  Region footprint   224

11.5.5.3  Product footprint  225

11.5.5.4  Type footprint       226

11.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        227

11.6.1      PROGRESSIVE COMPANIES         227

11.6.2      RESPONSIVE COMPANIES            227

11.6.3      DYNAMIC COMPANIES  228

11.6.4      STARTING BLOCKS         228

11.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 229

11.6.5.1  Detailed list of key startups/SMEs    229

11.7         VALUATION & FINANCIAL METRICS       230

11.7.1      FINANCIAL METRICS      230

11.7.2      COMPANY VALUATION 230

11.8         BRAND/SOFTWARE COMPARISON           231

11.9         COMPETITIVE SCENARIO             232

11.9.1      PRODUCT LAUNCHES   232

11.9.2      DEALS  233

11.9.3      EXPANSIONS     233

12            COMPANY PROFILES      234

12.1         KEY COMPANIES              234

12.1.1      MEDTRONIC      234

12.1.1.1  Business overview 234

12.1.1.2  Products offered   235

12.1.1.3  Recent developments           238

12.1.1.3.1                Product launches & approvals            238

12.1.1.3.2                Deals      239

12.1.1.3.3                Other developments             240

12.1.1.4  MnM view              240

12.1.1.4.1                Key strengths/Right to win 240

12.1.1.4.2                Strategic choices   240

12.1.1.4.3                Weaknesses and competitive threats 241

12.1.2      GE HEALTHCARE             242

12.1.2.1  Business overview 242

12.1.2.2  Products offered   243

12.1.2.3  Recent developments           244

12.1.2.3.1                Product launches & approvals            244

12.1.2.3.2                Deals      245

12.1.2.4  MnM view              246

12.1.2.4.1                Key strengths/Right to win 246

12.1.2.4.2                Strategic choices   246

12.1.2.4.3                Weaknesses and competitive threats 246

12.1.3      KONINKLIJKE PHILIPS N.V.          247

12.1.3.1  Business overview 247

12.1.3.2  Products offered   248

12.1.3.3  Recent developments           249

12.1.3.3.1                Product launches & enhancements    249

12.1.3.3.2                Deals      251

12.1.3.3.3                Other developments             252

12.1.3.4  MnM view              252

12.1.3.4.1                Key strengths/Right to win 252

12.1.3.4.2                Strategic choices   253

12.1.3.4.3                Weaknesses and competitive threats 253

12.1.4      ABBOTT               254

12.1.4.1  Business overview 254

12.1.4.2  Products offered   255

12.1.4.3  Recent developments           256

12.1.4.3.1                Product launches & approvals            256

12.1.4.3.2                Deals      258

12.1.4.4  MnM view              259

12.1.4.4.1                Key strengths/Right to win 259

12.1.4.4.2                Strategic choices   259

12.1.4.4.3                Weaknesses and competitive threats 259

12.1.5      BOSTON SCIENTIFIC CORPORATION     260

12.1.5.1  Business overview 260

12.1.5.2  Products offered   262

12.1.5.3  Recent developments           264

12.1.5.3.1                Product launches, enhancements, and approvals                 264

12.1.5.3.2                Deals      265

12.1.5.4  MnM view              266

12.1.5.4.1                Key strengths/Right to win 266

12.1.5.4.2                Strategic choices   266

12.1.5.4.3                Weaknesses and competitive threats 266

12.1.6      OMRON CORPORATION                267

12.1.6.1  Business overview 267

12.1.6.2  Products offered   268

12.1.6.3  Recent developments           269

12.1.6.3.1                Product & service launches 269

12.1.6.3.2                Deals      270

12.1.6.3.3                Expansions             270

12.1.7      BAXTER INTERNATIONAL, INC. 271

12.1.7.1  Business overview 271

12.1.7.2  Products offered   272

12.1.7.3  Recent developments           274

12.1.7.3.1                Product launches & approvals            274

12.1.7.3.2                Deals      276

12.1.8      BIOTRONIK        277

12.1.8.1  Business overview 277

12.1.8.2  Products offered   277

12.1.8.3  Recent developments           278

12.1.8.3.1                Product launches & enhancements    278

12.1.8.3.2                Deals      279

12.1.9      JOHNSON & JOHNSON  280

12.1.9.1  Business overview 280

12.1.9.2  Products offered   281

12.1.9.3  Recent developments           282

12.1.9.3.1                Deals      282

12.1.10   NIHON KOHDEN CORPORATION              283

12.1.10.1                 Business overview 283

12.1.10.2                 Products offered   284

12.1.10.3                 Recent developments           285

12.1.10.3.1             Product launches & approvals            285

12.1.10.3.2             Deals      286

12.1.10.3.3             Expansions             286

12.1.11   SIEMENS HEALTHINEERS AG      287

12.1.11.1                 Business overview 287

12.1.11.2                 Products offered   288

12.1.11.3                 Recent developments           288

12.1.11.3.1             Product launches  288

12.1.11.3.2             Deals      289

12.1.12   HONEYWELL INTERNATIONAL, INC.      290

12.1.12.1                 Business overview 290

12.1.12.2                 Products offered   291

12.1.13   ALIVECOR, INC.                 292

12.1.13.1                 Business overview 292

12.1.13.2                 Products offered   292

12.1.13.3                 Recent developments           293

12.1.13.3.1             Product & service launches 293

12.1.13.3.2             Deals      294

12.1.14   DRÄGERWERK AG & CO. KGAA  295

12.1.14.1                 Business overview 295

12.1.14.2                 Products offered   296

12.1.14.3                 Recent developments           296

12.1.14.3.1             Product launches  296

12.1.14.3.2             Deals      297

12.1.15   NONIN 298

12.1.15.1                 Business overview 298

12.1.15.2                 Products offered   298

12.1.15.3                 Recent developments           299

12.1.15.3.1             Product launches  299

12.1.15.3.2             Deals      299

12.1.16   RESMED               300

12.1.16.1                 Business overview 300

12.1.16.2                 Products offered   302

12.1.16.3                 Recent developments           302

12.1.16.3.1             Product launches  302

12.1.16.3.2             Deals      303

12.1.16.3.3             Expansions             304

12.1.16.3.4             Other developments             304

12.1.17   MASIMO               305

12.1.17.1                 Business overview 305

12.1.17.2                 Products offered   306

12.1.17.3                 Recent developments           308

12.1.17.3.1             Product launches & approvals            308

12.1.17.3.2             Deals      309

12.1.18   I-SENS, INC.        310

12.1.18.1                 Business overview 310

12.1.18.2                 Products offered   311

12.1.18.3                 Recent developments           313

12.1.18.3.1             Product launches & approvals            313

12.1.18.3.2             Deals      313

12.1.18.3.3             Expansions             313

12.1.19   ICU MEDICAL, INC.          314

12.1.19.1                 Business overview 314

12.1.19.2                 Products offered   315

12.1.19.3                 Recent developments           316

12.1.19.3.1             Product approvals 316

12.1.19.3.2             Deals      316

12.2         OTHER PLAYERS              317

12.2.1      AMD GLOBAL TELEMEDICINE  317

12.2.2      IHEALTH LABS  317

12.2.3      AEROTEL MEDICAL SYSTEMS    318

12.2.4      HUNTLEIGH HEALTHCARE LIMITED      319

12.2.5      INFINIUM MEDICAL        319

12.2.6      HAMILTON MEDICAL    320

13            APPENDIX           321

13.1         DISCUSSION GUIDE        321

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                326

13.3         CUSTOMIZATION OPTIONS        328

13.4         RELATED REPORTS         328

13.5         AUTHOR DETAILS           329

LIST OF TABLES

TABLE 1                IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES ON IOT MEDICAL DEVICES MARKET                 51

TABLE 2                MAJOR US HEALTHCARE DATA BREACHES                 57

TABLE 3                IOT MEDICAL DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 64

TABLE 4                INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)     65

TABLE 5                KEY BUYING CRITERIA FOR IOT MEDICAL DEVICES              66

TABLE 6                TESTS AND CERTIFICATION REQUIREMENTS FOR WIRELESSLY

CONNECTED MEDICAL DEVICES              67

TABLE 7                REGULATIONS AND STANDARDS GOVERNING CONNECTED MEDICAL DEVICES              70

TABLE 8                CLASSIFICATION OF MEDICAL DEVICES IN JAPAN   72

TABLE 9                CLASSIFICATION OF MEDICAL DEVICES IN CHINA  73

TABLE 10              AVERAGE COST OF IOT MEDICAL DEVICES, BY PRODUCT           75

TABLE 11              KEY PATENTS IN IOT MEDICAL DEVICES MARKET               78

TABLE 12              IOT MEDICAL DEVICES MARKET: LIST OF CONFERENCES AND EVENTS     81

TABLE 13              US ADJUSTED RECIPROCAL TARIFF RATES                 83

TABLE 14              IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            92

TABLE 15              VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            93

TABLE 16              VITAL SIGNS MONITORING DEVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            93

TABLE 17              BLOOD GLUCOSE MONITORS OFFERED BY KEY MARKET PLAYERS           94

TABLE 18              BLOOD GLUCOSE MONITORS MARKET, BY REGION, 2023–2030 (USD MILLION)          95

TABLE 19              ECG/HEART RATE MONITORS OFFERED BY KEY MARKET PLAYERS           96

TABLE 20              ECG/HEART RATE MONITORS MARKET, BY REGION, 2023–2030 (USD MILLION)          97

TABLE 21              BLOOD PRESSURE MONITORS OFFERED BY KEY MARKET PLAYERS           98

TABLE 22              BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     99

TABLE 23              MULTIPARAMETER MONITORS OFFERED BY KEY MARKET PLAYERS  100

TABLE 24              MULTIPARAMETER MONITORS MARKET, BY REGION, 2023–2030 (USD MILLION)          101

TABLE 25              OXIMETERS OFFERED BY KEY MARKET PLAYERS                 101

TABLE 26              OXIMETERS MARKET, BY REGION, 2023–2030 (USD MILLION) 102

TABLE 27              IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS              103

TABLE 28              IMAGING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)       103

TABLE 29              IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                104

TABLE 30              IMPLANTABLE CARDIAC DEVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            104

TABLE 31              IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS OFFERED

BY KEY MARKET PLAYERS            105

TABLE 32              IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS MARKET,

BY REGION, 2023–2030 (USD MILLION)   106

TABLE 33              PACEMAKERS OFFERED BY KEY MARKET PLAYERS              107

TABLE 34              PACEMAKERS MARKET, BY REGION, 2023–2030 (USD MILLION) 108

TABLE 35              IMPLANTABLE CARDIAC MONITORS OFFERED BY KEY MARKET PLAYERS            108

TABLE 36              IMPLANTABLE CARDIAC MONITORS MARKET, BY REGION,

2023–2030 (USD MILLION)            109

TABLE 37              PATIENT MONITORS OFFERED BY KEY MARKET PLAYERS              109

TABLE 38              PATIENT MONITORS MARKET, BY REGION, 2023–2030 (USD MILLION)            111

TABLE 39              RESPIRATORY DEVICES OFFERED BY KEY MARKET PLAYERS           111

TABLE 40              RESPIRATORY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)            112

TABLE 41              INFUSION PUMPS OFFERED BY KEY MARKET PLAYERS              113

TABLE 42              INFUSION PUMPS MARKET, BY REGION, 2023–2030 (USD MILLION)       113

TABLE 43              FETAL MONITORING DEVICES OFFERED BY KEY MARKET PLAYERS           114

TABLE 44              FETAL MONITORING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)          115

TABLE 45              NEUROLOGICAL DEVICES OFFERED BY KEY MARKET PLAYERS           116

TABLE 46              NEUROLOGICAL DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)            116

TABLE 47              VENTILATORS OFFERED BY KEY MARKET PLAYERS              117

TABLE 48              VENTILATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 117

TABLE 49              ANESTHESIA MACHINES OFFERED BY KEY MARKET PLAYERS           118

TABLE 50              ANESTHESIA MACHINES MARKET, BY REGION, 2023–2030 (USD MILLION)            118

TABLE 51              HEARING DEVICES OFFERED BY KEY MARKET PLAYERS              119

TABLE 52              HEARING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)       119

TABLE 53              OTHER IOT MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS  120

TABLE 54              OTHER IOT MEDICAL DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)          121

TABLE 55              IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)       123

TABLE 56              STATIONARY IOT MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS            124

TABLE 57              STATIONARY IOT MEDICAL DEVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            125

TABLE 58              IMPLANTABLE IOT MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS       126

TABLE 59             IMPLANTABLE IOT MEDICAL DEVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            127

TABLE 60              WEARABLE IOT MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS  128

TABLE 61              WEARABLE IOT MEDICAL DEVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            129

TABLE 62              OTHER DEVICE TYPES OFFERED BY KEY MARKET PLAYERS           130

TABLE 63              OTHER IOT MEDICAL DEVICE TYPES MARKET, BY REGION,

2023–2030 (USD MILLION)            130

TABLE 64              IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,

2023–2030 (USD MILLION)            132

TABLE 65              WI-FI-ENABLED IOT MEDICAL DEVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            133

TABLE 66              BLUETOOTH-ENABLED IOT MEDICAL DEVICES MARKET,

BY REGION, 2023–2030 (USD MILLION)   134

TABLE 67              ZIGBEE-ENABLED IOT MEDICAL DEVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            134

TABLE 68              OTHER IOT MEDICAL DEVICE CONNECTIVITY TECHNOLOGIES MARKET,

BY REGION, 2023–2030 (USD MILLION)   135

TABLE 69              IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)            137

TABLE 70              IOT MEDICAL DEVICES MARKET FOR HOSPITALS & CLINICS,

BY COUNTRY, 2023–2030 (USD MILLION)               138

TABLE 71              IOT MEDICAL DEVICES MARKET FOR NURSING HOMES, ASSISTED LIVING FACILITIES, LONG-TERM CARE CENTERS, AND HOME CARE SETTINGS,

BY COUNTRY, 2023–2030 (USD MILLION)               139

TABLE 72              IOT MEDICAL DEVICES MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               140

TABLE 73              IOT MEDICAL DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)            142

TABLE 74              NORTH AMERICA: IOT MEDICAL DEVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            144

TABLE 75              NORTH AMERICA: IOT MEDICAL DEVICES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            145

TABLE 76              NORTH AMERICA: VITAL SIGNS MONITORING DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         145

TABLE 77              NORTH AMERICA: IMPLANTABLE CARDIAC DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         146

TABLE 78              NORTH AMERICA: IOT MEDICAL DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         146

TABLE 79              NORTH AMERICA: IOT MEDICAL DEVICES MARKET,

BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION)                 146

TABLE 80              NORTH AMERICA: IOT MEDICAL DEVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               147

TABLE 81              US: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     148

TABLE 82              US: VITAL SIGNS MONITORING DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         148

TABLE 83              US: IMPLANTABLE CARDIAC DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         149

TABLE 84              US: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)            149

TABLE 85              US: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,

2023–2030 (USD MILLION)            149

TABLE 86              US: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                150

TABLE 87              CANADA: IOT MEDICAL DEVICES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            151

TABLE 88              CANADA: VITAL SIGNS MONITORING DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         151

TABLE 89              CANADA: IMPLANTABLE CARDIAC DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         152

TABLE 90              CANADA: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                152

TABLE 91              CANADA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,

2023–2030 (USD MILLION)            152

TABLE 92              CANADA: IOT MEDICAL DEVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            153

TABLE 93              EUROPE: IOT MEDICAL DEVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            154

TABLE 94              EUROPE: IOT MEDICAL DEVICES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            155

TABLE 95              EUROPE: VITAL SIGNS MONITORING DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         155

TABLE 96              EUROPE: IMPLANTABLE CARDIAC DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         156

TABLE 97              EUROPE: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                156

TABLE 98              EUROPE: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,

2023–2030 (USD MILLION)            156

TABLE 99              EUROPE: IOT MEDICAL DEVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            157

TABLE 100            GERMANY: IOT MEDICAL DEVICES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            158

TABLE 101            GERMANY: VITAL SIGNS MONITORING DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         158

TABLE 102            GERMANY: IMPLANTABLE CARDIAC DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         159

TABLE 103            GERMANY: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                159

TABLE 104            GERMANY: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION)                 159

TABLE 105            GERMANY: IOT MEDICAL DEVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            160

TABLE 106            UK: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     161

TABLE 107            UK: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            161

TABLE 108            UK: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            162

TABLE 109            UK: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)            162

TABLE 110            UK: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,

2023–2030 (USD MILLION)            162

TABLE 111            UK: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                163

TABLE 112            FRANCE: IOT MEDICAL DEVICES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            164

TABLE 113            FRANCE: VITAL SIGNS MONITORING DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         164

TABLE 114            FRANCE: IMPLANTABLE CARDIAC DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         165

TABLE 115            FRANCE: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                165

TABLE 116            FRANCE: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,

2023–2030 (USD MILLION)            165

TABLE 117            FRANCE: IOT MEDICAL DEVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            166

TABLE 118            ITALY: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     167

TABLE 119            ITALY: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            167

TABLE 120            ITALY: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            168

TABLE 121            ITALY: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                168

TABLE 122            ITALY: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,

2023–2030 (USD MILLION)            168

TABLE 123            ITALY: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                169

TABLE 124            SPAIN: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     170

TABLE 125            SPAIN: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            170

TABLE 126            SPAIN: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            171

TABLE 127            SPAIN: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                171

TABLE 128            SPAIN: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,

2023–2030 (USD MILLION)            171

TABLE 129            SPAIN: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                172

TABLE 130            REST OF EUROPE: IOT MEDICAL DEVICES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            173

TABLE 131            REST OF EUROPE: VITAL SIGNS MONITORING DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         173

TABLE 132            REST OF EUROPE: IMPLANTABLE CARDIAC DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         174

TABLE 133            REST OF EUROPE: IOT MEDICAL DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         174

TABLE 134            REST OF EUROPE: IOT MEDICAL DEVICES MARKET,

BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION)                 174

TABLE 135            REST OF EUROPE: IOT MEDICAL DEVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               175

TABLE 136            ASIA PACIFIC: IOT MEDICAL DEVICES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               177

TABLE 137            ASIA PACIFIC: IOT MEDICAL DEVICES MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               177

TABLE 138            ASIA PACIFIC: VITAL SIGNS MONITORING DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         178

TABLE 139            ASIA PACIFIC: IMPLANTABLE CARDIAC DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         178

TABLE 140            ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            178

TABLE 141            ASIA PACIFIC: IOT MEDICAL DEVICES MARKET,

BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION)                 179

TABLE 142            ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            179

TABLE 143            CHINA: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     180

TABLE 144            CHINA: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            181

TABLE 145            CHINA: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            181

TABLE 146            CHINA: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                181

TABLE 147            CHINA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,

2023–2030 (USD MILLION)            182

TABLE 148            CHINA: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)     182

TABLE 149            JAPAN: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     183

TABLE 150            JAPAN: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            184

TABLE 151            JAPAN: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            184

TABLE 152            JAPAN: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                184

TABLE 153            JAPAN: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,

2023–2030 (USD MILLION)            185

TABLE 154            JAPAN: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)     185

TABLE 155            INDIA: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     186

TABLE 156            INDIA: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            187

TABLE 157            INDIA: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            187

TABLE 158            INDIA: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                187

TABLE 159            INDIA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,

2023–2030 (USD MILLION)            188

TABLE 160            INDIA: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                188

TABLE 161            REST OF ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            189

TABLE 162            REST OF ASIA PACIFIC: VITAL SIGNS MONITORING DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         190

TABLE 163            REST OF ASIA PACIFIC: IMPLANTABLE CARDIAC DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         190

TABLE 164            REST OF ASIA PACIFIC: IOT MEDICAL DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         191

TABLE 165            REST OF ASIA PACIFIC: IOT MEDICAL DEVICES MARKET,

BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION)                 191

TABLE 166            REST OF ASIA PACIFIC: IOT MEDICAL DEVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               192

TABLE 167            LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            193

TABLE 168            LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            193

TABLE 169            LATIN AMERICA: VITAL SIGNS MONITORING DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         194

TABLE 170            LATIN AMERICA: IMPLANTABLE CARDIAC DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         194

TABLE 171            LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            195

TABLE 172            LATIN AMERICA: IOT MEDICAL DEVICES MARKET,

BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION)                 195

TABLE 173            LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            196

TABLE 174            BRAZIL: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     197

TABLE 175            BRAZIL: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            197

TABLE 176            BRAZIL: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            198

TABLE 177            BRAZIL: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                198

TABLE 178            BRAZIL: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,

2023–2030 (USD MILLION)            198

TABLE 179            BRAZIL: IOT MEDICAL DEVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            199

TABLE 180            MEXICO: IOT MEDICAL DEVICES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            200

TABLE 181            MEXICO: VITAL SIGNS MONITORING DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         200

TABLE 182            MEXICO: IMPLANTABLE CARDIAC DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         201

TABLE 183            MEXICO: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                201

TABLE 184            MEXICO: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,

2023–2030 (USD MILLION)            201

TABLE 185            MEXICO: IOT MEDICAL DEVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            202

TABLE 186            REST OF LATIN AMERICA: IOT MEDICAL DEVICES MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               203

TABLE 187            REST OF LATIN AMERICA: VITAL SIGNS MONITORING DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         203

TABLE 188            REST OF LATIN AMERICA: IMPLANTABLE CARDIAC DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         204

TABLE 189            REST OF LATIN AMERICA: IOT MEDICAL DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         204

TABLE 190            REST OF LATIN AMERICA: IOT MEDICAL DEVICES MARKET,

BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION)                 204

TABLE 191            REST OF LATIN AMERICA: IOT MEDICAL DEVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               205

TABLE 192            MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,

BY REGION, 2023–2030 (USD MILLION)   206

TABLE 193            MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               207

TABLE 194            MIDDLE EAST & AFRICA: VITAL SIGNS MONITORING DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         207

TABLE 195            MIDDLE EAST & AFRICA: IMPLANTABLE CARDIAC DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         208

TABLE 196            MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         208

TABLE 197            MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,

BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION)                 208

TABLE 198            MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               209

TABLE 199            GCC COUNTRIES: IOT MEDICAL DEVICES MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               210

TABLE 200            GCC COUNTRIES: VITAL SIGNS MONITORING DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         210

TABLE 201            GCC COUNTRIES: IMPLANTABLE CARDIAC DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         211

TABLE 202            GCC COUNTRIES: IOT MEDICAL DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         211

TABLE 203            GCC COUNTRIES: IOT MEDICAL DEVICES MARKET,

BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION)                 211

TABLE 204            GCC COUNTRIES: IOT MEDICAL DEVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               212

TABLE 205            REST OF MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               213

TABLE 206            REST OF MIDDLE EAST & AFRICA: VITAL SIGNS MONITORING DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         213

TABLE 207            REST OF MIDDLE EAST & AFRICA: IMPLANTABLE CARDIAC DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         214

TABLE 208            REST OF MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         214

TABLE 209            REST OF MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,

BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION)                 215

TABLE 210            REST OF MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               215

TABLE 211            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN IOT MEDICAL DEVICES MARKET, JANUARY 2022–MAY 2025              217

TABLE 212            IOT MEDICAL DEVICES MARKET: DEGREE OF COMPETITION 219

TABLE 213            IOT MEDICAL DEVICES MARKET: REGION FOOTPRINT       224

TABLE 214            IOT MEDICAL DEVICES MARKET: PRODUCT FOOTPRINT       225

TABLE 215            IOT MEDICAL DEVICES MARKET: TYPE FOOTPRINT       226

TABLE 216            IOT MEDICAL DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES   229

TABLE 217            IOT MEDICAL DEVICES MARKET: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025      232

TABLE 218            IOT MEDICAL DEVICES MARKET: DEALS, JANUARY 2022–MAY 2025               233

TABLE 219            IOT MEDICAL DEVICES MARKET: EXPANSIONS, JANUARY 2022–MAY 2025               233

TABLE 220            MEDTRONIC: BUSINESS OVERVIEW        234

TABLE 221            MEDTRONIC: PRODUCTS OFFERED        235

TABLE 222            MEDTRONIC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025    238

TABLE 223            MEDTRONIC: DEALS, JANUARY 2022–MAY 2025                 239

TABLE 224            MEDTRONIC: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2025               240

TABLE 225            GE HEALTHCARE: BUSINESS OVERVIEW                 242

TABLE 226            GE HEALTHCARE: PRODUCTS OFFERED                 243

TABLE 227            GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025    244

TABLE 228            GE HEALTHCARE DEALS, JANUARY 2022–MAY 2025        245

TABLE 229            KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW          247

TABLE 230            KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED             248

TABLE 231            KONINKLIJKE PHILIPS N.V: PRODUCT LAUNCHES & ENHANCEMENTS,

JANUARY 2022–MAY 2025               249

TABLE 232            KONINKLIJKE PHILIPS N.V: DEALS, JANUARY 2022–MAY 2025   251

TABLE 233            KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025          252

TABLE 234            ABBOTT: BUSINESS OVERVIEW 254

TABLE 235            ABBOTT: PRODUCTS OFFERED 255

TABLE 236            ABBOTT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025               256

TABLE 237            ABBOTT: DEALS, JANUARY 2022–MAY 2025                 258

TABLE 238            BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW          260

TABLE 239            BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED    262

TABLE 240            BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES, ENHANCEMENTS,

AND APPROVALS, JANUARY 2022–MAY 2025          264

TABLE 241            BOSTON SCIENTIFIC: DEALS, JANUARY 2022–MAY 2025              265

TABLE 242            OMRON CORPORATION: BUSINESS OVERVIEW                 267

TABLE 243            OMRON CORPORATION: PRODUCTS OFFERED                 268

TABLE 244            OMRON CORPORATION: PRODUCT & SERVICE LAUNCHES,

JANUARY 2022–MAY 2025               269

TABLE 245            OMRON CORPORATION: DEALS, OMRON CORPORATION 270

TABLE 246            OMRON CORPORATION: EXPANSIONS, OMRON CORPORATION 270

TABLE 247            BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW          271

TABLE 248            BAXTER INTERNATIONAL, INC.: PRODUCTS OFFERED             272

TABLE 249            BAXTER INTERNATIONAL, INC.: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–MAY 2025               274

TABLE 250            BAXTER: DEALS, JANUARY 2022–MAY 2025                 276

TABLE 251            BIOTRONIK: BUSINESS OVERVIEW           277

TABLE 252            BIOTRONIK: PRODUCTS OFFERED          277

TABLE 253            BIOTRONIK PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025          278

TABLE 254            BIOTRONIK: DEALS, JANUARY 2022–MAY 2025                 279

TABLE 255            JOHNSON & JOHNSON: BUSINESS OVERVIEW                 280

TABLE 256            JOHNSON & JOHNSON: PRODUCTS OFFERED                 281

TABLE 257            JOHNSON & JOHNSON: DEALS, JANUARY 2022–MAY 2025              282

TABLE 258            NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW          283

TABLE 259            NIHON KOHDEN CORPORATION: PRODUCTS OFFERED             284

TABLE 260            NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–MAY 2025               285

TABLE 261            NIHON KOHDEN CORPORATION: DEALS, JANUARY 2022–MAY 2025               286

TABLE 262            NIHON KOHDEN CORPORATION: EXPANSIONS, JANUARY 2022–MAY 2025               286

TABLE 263            SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW          287

TABLE 264            SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED             288

TABLE 265            SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025      288

TABLE 266            SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–MAY 2025   289

TABLE 267            HONEYWELL INTERNATIONAL, INC.: BUSINESS OVERVIEW          290

TABLE 268            HONEYWELL INTERNATIONAL, INC.: PRODUCTS OFFERED    291

TABLE 269            ALIVECOR, INC.: BUSINESS OVERVIEW  292

TABLE 270            ALIVECOR, INC.: PRODUCTS OFFERED  292

TABLE 271            ALIVECOR, INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2022–MAY 2025      293

TABLE 272            ALIVECOR, INC.: DEALS, JANUARY 2022–MAY 2025        294

TABLE 273            DRÄGERWERK AG & CO. KGAA: BUSINESS OVERVIEW          295

TABLE 274            DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED             296

TABLE 275            DRÄGERWERK AG & CO. KGAA: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025      296

TABLE 276            DRÄGERWERK AG & CO. KGAA: DEALS, JANUARY 2022–MAY 2025               297

TABLE 277            NONIN: BUSINESS OVERVIEW    298

TABLE 278            NONIN: PRODUCTS OFFERED   298

TABLE 279            NONIN: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025              299

TABLE 280            NONIN: DEALS, JANUARY 2022–MAY 2025                 299

TABLE 281            RESMED: COMPANY OVERVIEW                300

TABLE 282            RESMED: PRODUCTS OFFERED 302

TABLE 283            RESMED: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025              302

TABLE 284            RESMED: DEALS, JANUARY 2022–MAY 2025                 303

TABLE 285            RESMED: EXPANSIONS, JANUARY 2022–MAY 2025                 304

TABLE 286            RESMED: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025   304

TABLE 287            MASIMO: COMPANY OVERVIEW                305

TABLE 288            MASIMO: PRODUCTS OFFERED 306

TABLE 289            MASIMO: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025               308

TABLE 290            MASIMO: DEALS, JANUARY 2022–MAY 2025                 309

TABLE 291            I-SENS, INC.: COMPANY OVERVIEW         310

TABLE 292            I-SENS, INC.: PRODUCTS OFFERED          311

TABLE 293            I-SENS, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025    313

TABLE 294            I-SENS, INC.: DEALS, JANUARY 2022–MAY 2025                 313

TABLE 295            I-SENS, INC.: EXPANSIONS, JANUARY 2022–MAY 2025        313

TABLE 296            ICU MEDICAL, INC.: COMPANY OVERVIEW                 314

TABLE 297            ICU MEDICAL, INC.: PRODUCTS OFFERED                 315

TABLE 298            ICU MEDICAL, INC.: PRODUCT APPROVALS, JANUARY 2022–MAY 2025               316

TABLE 299            ICU MEDICAL, INC.: DEALS, JANUARY 2022–MAY 2025        316

LIST OF FIGURES

FIGURE 1              RESEARCH DESIGN         32

FIGURE 2              PRIMARY SOURCES         33

FIGURE 3              BREAKDOWN OF PRIMARY INTERVIEWS DEMAND SIDE AND SUPPLY SIDE:

BY COMPANY TYPE, DESIGNATION, AND REGION            35

FIGURE 4              SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS         36

FIGURE 5              CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 37

FIGURE 6              CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS,

OPPORTUNITIES, AND CHALLENGES     38

FIGURE 7              BOTTOM-UP APPROACH              38

FIGURE 8              TOP-DOWN APPROACH                39

FIGURE 9              DATA TRIANGULATION METHODOLOGY                 39

FIGURE 10            IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2025 VS. 2030(USD MILLION)       42

FIGURE 11            IOT MEDICAL DEVICES MARKET, BY TYPE, 2025 VS. 2030(USD MILLION) 43

FIGURE 12            IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,

2025 VS. 2030 (USD MILLION)      43

FIGURE 13            IOT MEDICAL DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)      44

FIGURE 14            GEOGRAPHICAL SNAPSHOT OF IOT MEDICAL DEVICES MARKET            45

FIGURE 15            RISING GLOBAL DEMAND FOR REMOTE PATIENT MONITORING

TO DRIVE MARKET GROWTH     46

FIGURE 16            STATIONARY MEDICAL DEVICES TO COMMAND LARGEST SHARE OF

ASIA PACIFIC MARKET IN 2024   47

FIGURE 17            CHINA TO RECORD HIGHEST CAGR IN GLOBAL MARKET               48

FIGURE 18            ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD       48

FIGURE 19            EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES               49

FIGURE 20            IOT MEDICAL DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          50

FIGURE 21            HEALTHCARE SPENDING, BY COUNTRY, 2023 (% OF GDP)               52

FIGURE 22            NUMBER OF SMARTPHONE USERS, BY COUNTRY, 2022 54

FIGURE 23            IOT MEDICAL DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 63

FIGURE 24            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS              65

FIGURE 25            KEY BUYING CRITERIA FOR IOT MEDICAL DEVICES              66

FIGURE 26            VALUE CHAIN ANALYSIS, 2024    74

FIGURE 27            IOT MEDICAL DEVICES MARKET: ECOSYSTEM                 75

FIGURE 28            PATENT PUBLICATION TRENDS (JANUARY 2015–MAY 2025) 76

FIGURE 29            TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) OF IOT MEDICAL DEVICES (JANUARY 2015–MAY 2025)            77

FIGURE 30            TOP APPLICANT COUNTRIES/REGIONS FOR IOT MEDICAL DEVICE PATENTS (JANUARY 2015–MAY 2025)                 78

FIGURE 31            IOT MEDICAL DEVICES MARKET: TRENDS/DISRUPTIONS IMPACTING

CUSTOMERS’ BUSINESSES           82

FIGURE 32            NORTH AMERICA: IOT MEDICAL DEVICES MARKET SNAPSHOT       144

FIGURE 33            ASIA PACIFIC: IOT MEDICAL DEVICES MARKET SNAPSHOT          176

FIGURE 34            REVENUE ANALYSIS OF KEY PLAYERS, 2024                 218

FIGURE 35            IOT MEDICAL DEVICES MARKET: MARKET SHARE ANALYSIS, 2024   219

FIGURE 36            IOT MEDICAL DEVICES MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2024       222

FIGURE 37            IOT MEDICAL DEVICES MARKET: COMPANY FOOTPRINT       223

FIGURE 38            IOT MEDICAL DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 228

FIGURE 39            EV/EBITDA OF KEY VENDORS   230

FIGURE 40            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA

OF KEY VENDORS            230

FIGURE 41            IOT MEDICAL DEVICES MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS   231

FIGURE 42            MEDTRONIC: COMPANY SNAPSHOT (2023)                 235

FIGURE 43            GE HEALTHCARE: COMPANY SNAPSHOT (2024)                 243

FIGURE 44            KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024)             247

FIGURE 45            ABBOTT: COMPANY SNAPSHOT (2024)  255

FIGURE 46            BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024)      261

FIGURE 47            OMRON CORPORATION: COMPANY SNAPSHOT (2024)    267

FIGURE 48            BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2024)             272

FIGURE 49            JOHNSON & JOHNSON: COMPANY SNAPSHOT (2024)    281

FIGURE 50            NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2024)             284

FIGURE 51            SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024)             287

FIGURE 52            HONEYWELL INTERNATIONAL, INC.: COMPANY SNAPSHOT (2024)             291

FIGURE 53            DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2024)             295

FIGURE 54            RESMED: COMPANY SNAPSHOT (2024)   301

FIGURE 55            MASIMO: COMPANY SNAPSHOT (2024)  306

FIGURE 56            I-SENS, INC.: COMPANY SNAPSHOT (2024)                 311

FIGURE 57            ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024)    315